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Abstract
Myelin-associated glycoprotein (MAG) has been detected in Schwann cells prior to the onset of myelination, suggesting its
functions in the initiation of myelination. However, transcriptional regulatory mechanisms of MAG remain to be elucidated. Here,
weanalyzed the promoter of the MAG gene by using luciferase reporter systems in the primary rat Schwann cells.We identified a
novel cis-acting element located 160 bp upstreamfrom the MAG transcription initiation site. Using the identified cis-element as a
bait, we performed yeast one-hybrid screening and isolated a cDNA encoding a RNF10 as a putative trans-acting protein. When
overexpressed in Schwann cells, RNF10 enhanced the activity of the MAG promoter. When RNF10 expression in Schwann cells
was knocked down by siRNA, endogenous MAG mRNA and protein expression decreased. Furthermore, we evaluated myelin
synthesis using Schwann cell-DRG neuron cocultures. When Schwann cells were infected with retrovirus expressing RNF10 siRNA,
myelin formation was inhibited. These data suggest that RNF10 regulates MAG expression and is required for myelin formation.
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Introduction
Myelin sheath is a unique component of the nervous system. It
ensheaths the axons in the peripheral nervous system (PNS) and
central nervous system (CNS) of vertebrates. It increases axonal
conduction velocity, thereby allowing saltatory conduction [1].
Given the functional importance of myelin, it is of particular
interest to clarify the molecular mechanisms underlying the
differentiation of myelinating glial cells and formation and
maintenance of myelin. It is widely accepted that several molecules
expressed on axons, such as neuregulin [2], convey axonal signals
that trigger myelin-forming cells, namely, Schwann cells in the
PNS, to initiate the process of myelination. Therefore, molecules
expressed at the axon-glia junction are also likely to be involved in
the onset of myelination. Among several myelin-membrane
proteins, only myelin-associated glycoprotein (MAG) appears in
the periaxonal area of the Schwann cell [3,4].
The MAG expression is induced when a 1:1 relationship is
established between Schwann cells and axons; such a relationship
facilitates the contact of the processes of each Schwann cell to the
axon at the promyelinating Schwann cell stage. MAG has been
detected on Schwann cell surface prior to the onset of myelination [5]
and has long been thought to be involved in glia-axon interactions
[6]. Previous reports have shown that MAG performs important
positive functions in the differentiation of myelinating glial cells, glia-
axon interactions, and myelination [7]. Therefore, MAG is believed
to play an important role in the onset of myelination, and the
regulatory mechanisms underlying MAG expression may be
important in the initiation of myelination processes. Along this line,
our previous study revealed that activation of the PI3K pathway
induced MAG expression simultaneously with Schwann cell
differentiation [8]. However, the transcriptional regulatory mecha-
nisms underlying MAG expression remain poorly understood. In the
present study, we investigated the regulatory mechanismsof Schwann
cell myelination through analyzing the regulation of MAG expression
at the transcriptional level.
The MAG promoter contains neither the canonical TATA box
nor initiator motifs [9]. The specific cis-elements and the
transcriptional regulatory factors remain to be identified [10].
Since the expression of MAG is closely related to the onset of
myelination, transcriptional regulation of the MAG gene appears
to have a strong influence on the mechanism underlying the
initiation of myelination. Therefore, in this study, we specifically
aimed to identify the positive cis-acting element in the MAG gene
and the specific transcriptional regulatory factor in Schwann cells,
with the ultimate goal to elucidate the regulatory mechanisms that
control the gene activity in differentiating Schwann cells.
Results
The 2162/2143 Region is Essential for MAG Promoter
Activity
To identify the cis-element(s) required for the promoter activity
of the rat MAG gene, serial and internal deletion luciferase reporter
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using transient transfection assays. The promoter region of the
MAG gene obtained from rat genomic DNA was cloned into a
pGL3-Basic luciferase reporter vector. To measure the basal
activity, an empty pGL3-Basic vector was used as a control vector.
The reporter construct p2752, containing rat MAG promoter
region extending from 22752 to +78, was adequate for the
detection of reporter gene expression in Schwann cells. Sequential
deletion of the region between 22752 and 2162 in the rat MAG
promoter caused a modest increase in the promoter activity.
However, further deletion of a 9-nucleotide stretch (2162 to
2153) resulted in a marked decrease in the reporter gene activity
in Schwann cells. Deletion of the sequence between 2162 and
2153 in the p283 construct (p283D) reduced the luciferase
expression level, which was then similar to the level in p153. These
data suggested that a positive regulatory element exists within the
region from 2162 to 2153. The deletion analysis of the MAG
promoter revealed the induction of luciferase activity in Schwann
cells but much less in rat osteosarcoma (ROS) cells. Therefore, the
MAG promoter would contain a Schwann cell-specific cis-acting
element (Fig 1A).
To examine whether a 10-bp sequence between 2162 and
2153 is adequate to function as a cis-element, a 10-, 15-, or 20-bp
tandem repeat sequence downstream from position 2162 was
appended to the 59 end of the MAG promoter sequence of p162,
thereby generating p162A, p162B, and p162C constructs,
respectively (Fig 1B), as previously described [11]. Only the
construct containing the 20-bp (2162 to 2143) tandem repeats
(p162c/C) could increase the luciferase activity. The triple repeat
of the 20 bp (p162C) increased luciferase activity than the double
repeat (p162c) (Fig 1B).
The deletion construct p77 exhibited a low luciferase activity,
and this activity was induced only by the core promoter (225 to
+40) [12]. To examine the importance of the 59 end of the 20-bp
sequence, a 16- or 20-bp tandem repeat sequence upstream from
position 2143 was appended to the 59 end of the minimal MAG
promoter sequence p77, thereby generating p77D and p77C
constructs, respectively (Fig 1C). Identical to the abovementioned
observation, only the construct containing 20-bp tandem repeats
(p77C) could markedly increase the luciferase activity (Fig 1C).
Therefore, we believe that this 20-bp sequence (2162 to 2143: 59-
ACAAGGGCCCCTTTGTGCCC -39) is essential for the activa-
tion of transcription. We designated this sequence as ‘‘Schwann
cell-specific element (SSE).’’ This sequence is completely con-
served among the rat, human, and mouse (Table 1).
Isolation of Transcriptional Regulatory Factor RNF10 that
Interacts with the 20-bp Cis-acting Element Region in the
MAG Promoter
To determine whether the identified cis-acting element, SSE,
can recruit transcription factors to regulate the promoter activity,
electrophoretic mobility shift assay (EMSA) was carried out using
nuclear extracts from rat Schwann cells. We constructed a double-
stranded oligonucleotide spanning the region from 2167 to 2138
in the MAG promoter, including the 20-bp cis-acting element
(2162 to 2143), with flanking sequences at both the ends. The
SSE sequence, containing the cis-acting element, could form
sequence-specific DNA-protein complexes with the nuclear
extracts of rat Schwann cells (Fig 2A); this suggested the presence
of endogenous transcriptional regulatory factors in Schwann cells.
Since the SSE sequence does not contain previously identified
transcription factor-binding sites, we screened a cDNA fusion
library, which was generated from rat Schwann cells, by using the
SSE sequence as a probe in yeast one-hybrid screening. We
identified 10 candidate genes containing partial in-frame sequenc-
es, namely, Wbp1, Rnd2, Sub1, Rbm3, Rbm5, LOC308081, Brp44l,
Pja1, Zdhhc16, and RNF10, which encode proteins that appear to
exhibit DNA-binding activity. Luciferase reporter gene assay
revealed that among these candidate genes, only RNF10 activated
the MAG promoter when overexpressed in Schwann cells. Full-
length RNF10 was subsequently isolated from Schwann cell cDNA
by RT-PCR with appropriate primers. The final open reading
frame was found to potentially encode an 802-amino acid protein
with a molecular mass of 88 kDa. RING finger motif is a variant
of zinc finger motif present in a family of proteins, including
transcription regulators. RNF10 has been shown to be ubiqui-
tously expressed and has been previously isolated from a mouse
brain cDNA library [13].
RNF10 Directly Activates the MAG Promoter in Schwann
Cells
To determine whether RNF10 directly binds to the SSE, we
synthesized RNF10 by in vitro translation and examined its
binding to double-stranded SSE oligonucleotide by EMSA.
RNF10 expression plasmids were constructed using vector
pCITE4. The EMSA revealed the binding of RNF10 to wild-
type SSE oligonucleotide, whereas proteins from in vitro
translation reaction with control empty vector pCITE4 did not
form a complex with oligonucleotide (Fig 2B). In order to map the
RNF10-binding motif within the SSE sequence, we analyzed a
series of oligonucleotides in which 2 bases were mutated at a time.
Such a condition was employed because the luciferase assay had
revealed the importance of the first half of the SSE sequence in
transcription. Our analysis revealed that mutation of any 1 pair of
bases in the ACAAGGGCCC sequence (Fig 2C) abrogated
RNF10 binding in varying degrees (Fig 2D). Furthermore, we
performed EMSA supershift analysis. Myc epitope-tagged RNF10
was expressed in Schwann cells by retrovirus-mediated gene
transfer. EMSA was performed using nuclear extracts from
Schwann cells and anti-Myc antibody. The presence of the anti-
Myc antibody created the supershift band (Fig. 2E).
We further performed chromatin immunoprecipitation (ChIP)
assays to investigate the association of RNF10 with the SSE in
Schwann cells. Myc epitope-tagged RNF10 was expressed in
Schwann cells by retrovirus-mediated gene transfer. Sheared
chromatin was prepared from these cells, Myc-RNF10 was
immunoprecipitated, and the DNA present in the immunopre-
cipitated material was analyzed by PCR. The binding of Myc-
RNF10 to the SSE region of the MAG promoter was demonstrated
by PCR performed with specific primers. The specificity of Myc-
tagged RNF10 association with the MAG promoter regions of the
chromatin is supported by the observation that anti-Myc
antibodies could not precipitate a 59 regulatory region of the
Gapdh gene that does not contain SSE-like sequence (Fig 2F).
Taken together, these data suggest that RNF10 binds to the DNA
fragment containing the SSE sequence.
To determine whether RNF10 binds to the MAG promoter and
enhances promoter activities, Schwann cells were cotransfected
with an expression construct for RNF10 (pcDNA3.1-RNF10) and
a luciferase reporter construct, p77 or p77C/p153 or p162C
(Fig 1C). Overexpression of RNF10 in Schwann cells increased the
MAG promoter activity by 100%, as compared to the activity in
the control cells; however, this was observed only when the
reporter constructs contained the SSE region (Fig 3A). We also
carried out the same experiments using ROS cells. In ROS cells,
overexpression of RNF10 increased the MAG promoter activity by
60%, as compared to the activity in the control cells (Fig 3B).
However, the degree of promoter activation in ROS cells was not
RNF10 Regulates Myelination
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3464Figure 1. Luciferase activity of Schwann cells transiently transfected with a MAG promoter construct. (A) Transient cotransfections of
Schwann cells and ROS cells using various rat MAG reporter constructs. The largest MAG-luciferase reporter plasmid had a 2.7-kb promoter. Numerous
sequences with 59 deletion were constructed, including reporter plasmids containing 283-, 162-, 153-, and 77-bp segments of the MAG promoter. A
sequence with internal deletion of a segment from 2162 to 2153 was also constructed. The observed firefly luciferase activity is normalized with the
Renilla luciferase activity and the results are expressed as fold induction compared with empty vector in Schwann cells. Deletion of a region between
2162 and 2153 greatly reduced the luciferase activity. In contrast, the luciferase activity showed subtle changes in the ROS cell. (B, C) To examine the
positive effects of the sequence between 2162 and 2153 on the promoter activity, we generated and analyzed various lengths of tandem repeats
downstream from 2162 (B) and upstream from 2143 (C). The normalized luciferase activity is expressed as fold induction compared with the value of
either p162 in (B) or p77 in (C) respectively. Only the reporter constructs bearing 20-bp tandem repeats (2162 to 2143) could increase the luciferase
activity in a repeat number-dependent manner. Therefore, we believe that this 20-bp sequence (59-ACAAGGGCCCCTTTGTGCCC-39) is required and
sufficient for the activation of the MAG promoter and that it is a cis-acting element.
doi:10.1371/journal.pone.0003464.g001
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RNF10 mRNA expression was detected between SC and ROS
cells By RT-PCR (Fig 3C), these results suggest that RNF10 can
activate the MAG promoter more effectively in Schwann cells than
in ROS cells.
Furthermore, to examine the role of the RING finger domain,
Schwann cells were cotransfected with the vector expressing the
RING finger domain deletion mutant of RNF10 (DRFD) and the
luciferase reporter construct p77C. The DRFD construct did not
activate the MAG promoter (Fig 3D).Taken together, RNF10 directly
binds to the MAG promoter and enhances promoter activities, and
the RING finger domain is required for this interaction.
In order to induce the transcriptional control activity,
transcription factors must enter the nuclear compartment.
RNF10 protein contains 3 nuclear localization signals in the
592–600 aa, 605–610 aa, and 785–793 aa regions [13]; hence, it
would appear that the RNF10 protein is localized in the nucleus.
We confirmed the nuclear localization of RNF10 by indirect
immunofluorescence (Fig 3E). Myc epitope-tagged RNF10 was
expressed by retrovirus-mediated gene transfer. Tag immuno-
staining showed nuclear staining.
Specific Silencing of the RNF10 Gene by RNF10 Small
Interfering RNA in Schwann Cells
To investigate the physiological role of RNF10 in Schwann
cells, we interfered in its function by using the small interfering
RNA (siRNA). Transfection of the siRNA expression vector into
Schwann cells reduced RNF10 mRNA expression to 10% of that
in the control cells (Fig 4A). To determine the luciferase activity,
the tandem SSE containing the luciferase reporter construct
p162C was cotransfected with either RNF10 siRNA or control
EGFP siRNA expression vector into Schwann cells. RNF10
knockdown exhibited a significant decrease in the MAG promoter
activity; the luciferase activity in the RNF10 siRNA-transfected
cells was 40% of that in the EGFP siRNA-transfected cells (Fig 4B).
Subsequently, Schwann cells were stably transfected with a
retrovirus-based RNF10 siRNA. The RNF10 mRNA levels in the
retroviral siRNA-transfected cells were reduced to 10% compared
with the control EGFP siRNA- transfected cells (Fig 4A). Then, we
performed EMSA analysis using nuclear extracts prepared from
Schwann cells transfected with a retroviral RNF10 siRNA and
control EGFP siRNA. The nuclear extracts of RNF10 siRNA-
treated Schwann cells were not able to form a DNA-protein
complex with SSE-containing DNA probe in gel shifts (Fig. 4C).
This result further confirmed the specificity of RNF10 in forming
complex with SSE sequence.
Using quantitative RT-PCR and western blotting, we next
measured the MAG mRNA and protein expression levels in the
cells infected with RNF10 siRNA-expressing retrovirus. In RT-
PCR, RNF10 siRNA reduced the MAG mRNA levels to 25% of
that in the control EGFP siRNA-treated cells (Fig 4D). Western
blotting showed that the RNF10 siRNA markedly reduced the
MAG protein expression level, when compared with the level in
the control EGFP siRNA-treated cells (Fig 4E). We also measured
the mRNA levels of myelin protein zero (MPZ/P0) and myelin
basic protein (MBP). No difference was observed in the mRNA
levels of MPZ and MBP between the RNF10 siRNA-treated and
control cells (Fig 4D). This suggests that RNF10 specifically
regulates MAG gene expression and does not influence the
expression of other Schwann cell differentiation markers.
RNF10 Negatively Regulates Schwann Cell Proliferation
In addition, we examined the effect of RNF10 on the cell cycle
regulation in Schwann cells. In MTT assay, compared to control
cells, the number of stable RNF10 knockdown cells exhibited 40%
greater increase on day 4 (Fig 5A). To determine whether the
increase of cell number was caused by the promotion of cell cycle
progression, we performed BrdU incorporation experiments.
BrdU incorporation was significantly increased (80% greater) in
stable RNF10 knockdown cells compared with controls (Fig 5B).
These results suggest that RNF10 is involved in Schwann cell
proliferation.
Knockdown of RNF10 in Schwann Cells Inhibits Myelin
Formation
Finally, to investigate the potential role of RNF10 in the process
of myelination, we cocultured Schwann cells with DRG neurons,
which is a well-established in vitro system for studying myelination.
Schwann cells were stably transfected with a retrovirus-based
RNF10 siRNA prior to initiating the coculture and were added to
purified DRG neuron cultures. Using this method and retrovirus
vectors, we could knockdown the endogenous RNF10 activity in
Schwann cells without affecting the neurons. The medium was
then replaced with myelin-inducing medium containing ascorbate;
after 2 weeks of coculture, the cells were fixed and immunostained
with an anti-MBP antibody. Myelin segments were clearly visible
in the EGFP siRNA retrovirus-transfected cultures. Compared
with the control EGFP siRNA, the RNF10 siRNA resulted in
more than 80% reduction in the total number of myelin segments
per microscopic visual field. DRG neurons exhibited normal
neurite outgrowth in both cultures. There was no difference in cell
density between both cultures (Fig 6A, B). This result suggests that
RNF10 expression in Schwann cells is indispensable for the
Schwann cell differentiation and myelin formation.
Discussion
In this study, we cloned and sequenced the promoter and 59
upstream flanking regions of the rat MAG gene. The 59 deletion
analysis of the MAG promoter revealed that the 20-bp sequence
extending from nucleotide 2162 to 2143 could induce promoter
activity at levels similar to that induced by the longest reporter
construct. The 20-bp sequence ACAAGGGCCCCTTTGTGCCC
(from 2162 to 2143), which contained no known transcriptional
factor-binding sites, was identified as a novel cis-acting element and
was designated SSE. This sequence has not been identified in
previous studies related to the MAG gene promoter, probably due to
the differences in experimental conditions (we used Schwann cell
primary culture instead of the C6 glioma cell line, which has been
used in other studies). This sequence is completely conserved in the
Table 1. Comparison of the promoter region of the MAG
gene.
RAT: aga------------gctgcccagcctcagccctagccctgtg
MOUSE: …cccaggaatcaa………t.c…………ga..
HUMAN: .a.cccaggcgtcag………t.cg…..c------…
RAT: gtgacaagggcccctttgtgcccccctcccccgggggcaggga
MOUSE: …………………………………….
HUMAN: ……………………………….a…..
Sequence alignments of the MAG promoter region. Identities are indicated by
dots and gaps by dashes. Bold characters show the 20 bp MAG promoter cis-
element (2162/2143), designated ‘‘SSE’’. SSE sequence is completely
conserved between Rat, Mouse and Human.
doi:10.1371/journal.pone.0003464.t001
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PLoS ONE | www.plosone.org 4 October 2008 | Volume 3 | Issue 10 | e3464Figure 2. Schwann cell nuclear extract and synthesized RNF10 can bind to the 20-bp MAG promoter cis-element (2162/2143)
designated as ‘‘SSE.’’ (A) EMSA for the binding of nuclear factors. The binding of Schwann cell nuclear extracts (10 mg) with the DIG-labeled MAG
promoter fragment (2167/2138) was tested in the absence of a specific competitor (lane 1) and in the presence of a 100-fold molar excess of the
unlabeled fragment (lane 2). The arrow indicates DNA-protein complexes. (B) RNF10 was in vitro translated from RNF10-pCITE4 plasmid. DNA binding
activity of RNF10 was analyzed using DIG-labeled MAG promoter oligonucleotide as probe. Translation reaction products with empty vector pCITE4
were used as control. 100-fold molar excess of the unlabeled fragment was used as competitor. Arrows denote the positions of the DNA–RNF10
complex. RNF10 is able to form specific DNA-protein complex with MAG promoter oligonucleotide containing ‘‘SSE’’ sequence. (C) Serial 20-bp
RNF10 Regulates Myelination
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SSE for yeast one-hybrid screening. Consequently, we identified
RNF10 as a protein capable of bindingto this critical segment of the
MAGpromoterregulatory region.Thespecificityof thisbinding was
independently confirmed by EMSA and ChIP.
RNF10 is one of the members of the RNF, which has generally
been implicated in the development, transcriptional regulation,
signal transduction, DNA repair, apoptosis, and oncogenesis [14].
Moreover, RNF10 is a highly conserved gene, exhibiting 96%
homology between rat and mouse and 90% homology between rat
and human. Some members of the RNF have been shown to bind
with DNA and function as transcriptional activators [15,16].
RNF10 has been recently shown to associate with Mesenchyme
Homeobox 2 (MEOX2) transcription factor, which regulates the
proliferation, differentiation, and migration of vascular smooth
muscle cells and cardiomyocytes [17]. Although RNF10 has not
been investigated in the context of the nervous system, several
databases have implicated its expression in the nervous system. We
also confirmed the elevation in the RNF10 mRNA level in the rat
embryonic PNS (data not shown). Taken together, RNF10 can be
considered as a transcription factor participating in the peripheral
nerve development and Schwann cell differentiation.
Our data demonstrates that RNF10 binds to the SSE in the MAG
gene promoter to enhance promoter activities; however, RNF10
may require some partner molecules to perform its function. The
existence of such molecules can be predicted based on the findings
that the MAG gene promoter showed a higher activity in the
Schwann cell background compared to that in the ROS cell
background. The difference can be attributed to the lack of partner
molecules in ROS cells. The precise mechanisms in the RNF,
including RNF10, are not completely understood; nonetheless,
RNF10 has been reported to form a complex with MEOX2 to
regulate transcriptional activities. Therefore, it appears that RNF10
requires a Schwann cell-specific-binding partner to regulate
Schwann cell functions. Further studies are required to elucidate
such molecules, and these studies would facilitate the understanding
of more precise mechanisms underlying RNF10 functions.
Using siRNA, we showed that the loss-of-function of RNF10 in
Schwann cellsresulted ina decreased MAGexpression and reduced
myelination in Schwann cell/neuron cocultures. However, in the
gain-of-functionexperiments,the luciferase assaydemonstrated that
the overexpression of RNF10 in Schwann cells by vector
transfection or retrovirus infection caused an increase in the MAG
promoter activity; however, no detectable difference was observed
in myelination when compared with the control cells (data not
shown). These results suggest that RNF10 is an essential molecule
forinitiatingmyelinationinSchwanncellsbutisnotabletopromote
myelination independently. This interpretation is conceivable
because biological processes such as myelin formation involve
many steps, and the molecules in each step interact mutually to
organize the processes. Therefore, it is intriguing to elucidate the
relation between RNF10 and other Schwann cell-related transcrip-
tional factors such as Oct-6 and Krox20. Since MAG expression is
induced in the early stages of myelination, we assume that RNF10
participates in the initiation of myelination. Further, it is important
to clarify the stage at which RNF10 is indispensable for Schwann
cell differentiation by using RNF10-deficient mice.
We identified RNF10 as a transcriptional regulator of the MAG
gene, but we speculate that other target molecules are also regulated
by RNF10. Our results indicate that RNF10 is required for both
Schwann cell myelination and MAG expression. However,
considering that MAG-deficient mice are capable of forming the
myelin structure with modest abnormalities in the PNS [18,19],
RNF10 probably regulates myelination by not only MAG
expression but also other pathways. Some sequences, similar to
the SSE, exist in the gene promoter regions of the rat, mouse, and
human, suggesting that RNF10 may also regulate other gene
expressions. However, we have not yet identified any myelin-related
genes near the SSE-like motif region. On the other hand, since the
knockdown of RNF10 in Schwann cells induced cell proliferation,
we conjecture that RNF10 may be involved in exiting from cell
cycle to initiate terminal differentiation and myelination.
In conclusion, we prove that RNF10 binds to the MAG
promoter and regulates MAG expression and myelin formation in
Schwann cells. RNF10 can be considered as a regulator of
Schwann cell differentiation and myelination. These results were
obtained by in vitro experiments. The generation of RNF10-
knockout mice should facilitate the understanding of the in vivo
biological function of RNF10.
Materials and Methods
Luciferase Reporter Construction and Assay
To generate reporter construct p2752, the 22752 to +78 bp of
the gene (+1 bp: transcriptional initiation site shown in reference
[20]) of the rat MAG promoter was subcloned into the KpnI, NheI
site of pGL3-Basic (Promega). To generate p153 was digested with
ApaI and KpnI, ligated, and sequenced. For reporters p283, p162,
p77, and p283D were generated by PCR with p2752 as the
template. Tandem repeats mutation constructs (p162A,B,C)
generated by PCR using the primer to which desired sequence
was added with p162 as the template. Reporters p77D,C were
generated by ligation of oligo insert into upstream of promoter
sequence in p77. These constructs were confirmed by sequencing.
For luciferase assay, cells were seeded on 24-well plates, cultured
overnight, and transfected with the plasmids by using the
FuGENE 6 (Roche Biochemicals). Before transfection, Schwann
cells were grown in medium containing 2 mM forskolin and 2 nM
recombinant neuregulin (rh-HRG-1; Genzyme) and after trans-
fection, cells were incubated in medium with 2 mM forskolin and
without neuregulin. The transfected cells were cultured 48 h
before harvesting to measure luciferase activity. Cell lysate was
assayed by the dual-luciferase (firefly luciferase and control
Renilla) reporter assay system from Promega.
Cell cultures
Primary rat Schwann cells were isolated and cultured using the
modified method of Brockers et al. [21,22]. Briefly, Schwann cells
mutant oligonucleotides of the 2162/2153 region of the MAG promoter cis-element were generated. The flanking sequences are indicated in small
typeface, and mutated bases are indicated in italics and bold. (D) EMSA using DIG-labeled mutant oligonucleotides and in vitro-translated RNF10. Any
mutation abrogated DNA-protein complex formation in varying degrees. The arrow indicates the DNA-RNF10 complexes. (E) EMSA-supershift analysis
of Myc-RNF10. Myc epitope-tagged RNF10 was expressed in Schwann cells by retrovirus-mediated gene transfer. Nuclear extracts were used for the
EMSA with a WT probe. DNA-protein complex was observed (arrow). Anti-Myc antibody was added for supershift analysis. The presence of the anti-
Myc antibody created the supershift band (arrowhead). (F) Myc-RNF10 was expressed in Schwann cells by retroviral transduction. ChIP assay followed
by PCR analyses was performed on Myc-tagged RNF10. A portion of the rat Gapdh promoter region that does not contain ‘‘SSE’’-like sequence was
amplified to control for specificity. Input DNA was obtained from formaldehyde-crosslinked sonicated chromatin without immunoprecipitation. IgG
was used as negative control.
doi:10.1371/journal.pone.0003464.g002
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PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3464Figure 3. RNF10 activates MAG promoter activity in Schwann cells. (A) Schwann cells were cotransfected with an expression construct for
RNF10 (pcDNA3.1-RNF10) and MAG-promoter-LUC with (p77C, p162C) or without (p77, p153) the tandem SSE region. Overexpression of RNF10
increased the MAG promoter activity in Schwann cells by 100% when compared with the activity in the control cells only when the reporter
constructs contained the SSE region. Thus, RNF10 increases the promoter activity in a cis-element-dependent manner. (B) Cotransfection of an
expression construct for RNF10 (pcDNA3.1-RNF10) and MAG-promoter-LUC containing the tandem SSE into ROS cells. The MAG promoter activity in
the ROS cells increased by 60% when compared with the activity in the control cells. However, the degree of activation in ROS cells was not as high as
that in the Schwann cells. (C) There was no difference in endogenous RNF10 mRNA expression between SC and ROS cells. (D) Cotransfection of an
expression construct for the RING finger domain-deletion mutant of RNF10 (DRFD) and MAG-promoter-LUC containing the tandem SSE into Schwann
cells. The RING finger domain-deletion construct did not activate the MAG promoter. (E) Indirect immunofluorescence of Schwann cells indicated the
nuclear localization of RNF10. Schwann cells stably expressed Myc epitope-tagged RNF10 by retrovirus-mediated gene transfer. Cells were
immunostained with an anti-Myc antibody, and the nucleus was stained with Hoechst 33342. The arrow heads show that tagged RNF10 was almost
exclusively located in the nucleus in dot-like structures. The normalized luciferase activity is expressed as fold induction compared with the valueo f
p77/mock or p153/mock in (A), p77/mock in (B) and p77C/mock in (D). *p,0.01; Student’s t test. Error bars show mean6SD.
doi:10.1371/journal.pone.0003464.g003
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PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3464Figure 4. Specific silencing of the RNF10 gene with RNF10 siRNA in Schwann cells. (A) Schwann cells were transfected with either RNF10
siRNA or control EGFP siRNA expression vector. At 48 h after transfection, quantitative RT-PCR analysis showed that the relative RNF10 mRNA levels in
the RNF10 siRNA-treated cells had reduced to 10% of that in the control EGFP siRNA-treated cells (left). Retroviral siRNA showed approximately the
same results (right). (B) Downregulation of MAG promoter activity by RNF10 siRNA. Schwann cells were cotransfected with a MAG-promoter-LUC
containing tandem SSE and RNF10 vector or control EGFP siRNA expression vector. Luciferase activity was measured 48 h posttransfection. RNF10
siRNA suppressed the promoter activity to 40% of that in the control cells. (C) EMSA using Retrovirus-mediated RNF10 siRNA Schwann cells. Schwann
cells were stably transfected with a retrovirus-based RNF10 siRNA and control EGFP siRNA. Nuclear extracts were used for the EMSA with a WT probe.
DNA-protein complex was observed with the control nuclear extract (arrow), while the nuclear proteins of RNF10 siRNA Schwann cells could not form
a DNA-protein complex. (D) Schwann cells were infected with a retrovirus expressing RNF10 siRNA or control EGFP siRNA, selected in puromycin, and
analyzed for the expression of MAG by quantitative RT-PCR analysis. Retrovirus-mediated RNF10 siRNA specifically reduced the MAG mRNA
expression levels to 25% of that in the control. No difference was observed in the mRNA levels of MPZ and MBP between the RNF10 siRNA-treated
and control cells. (E) Western blotting using an anti-MAG or anti-actin antibody of Schwann cells infected with either control EGFP siRNA or RNF10
siRNA-expressing retrovirus. RNF10 siRNA markedly reduced the MAG protein expression in Schwann cells. *p,0.01; Student’s t test. Error bars show
mean6SD.
doi:10.1371/journal.pone.0003464.g004
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DMEM containing 10% FBS. The following day, the medium was
supplemented to contain 10 mM AraC to kill dividing fibroblasts
for 48 h. For routine culture the cells were grown on poly-L-lysine-
coated tissue culture dishes in DMEM containing 10% fetal
bovine serum, 2 mM forskolin and 2 nM neuregulin.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts from rat primary cultured Schwann cells were
prepared using the NE-PER kit as per manufacturer’s recommen-
dations (Pierce). RNF10 proteins were in vitro transcribed and
translated from RNF10-pCITE4 plasmid using the TnT(R) Quick
Coupled Transcription/Translation system (Promega).
The sequences of the oligonucleotide probes used were as
Fig 2B. Synthesized double-stranded oligonucleotides were then
DIG end-labeled, and EMSA was performed utilizing the DIG gel
shift kit as per manufacturer’s recommendations (Roche). Binding
reactions were performed in the mixture containing nuclear
proteins (3 mg) or 2 ml of in-vitro translated products, poly(d(I-C))
(0.5 mg), and the DIG-labeled probe (15 fM) in a final volume of
20 ml of reaction buffer. The complexes were separated on 6%
polyacrylamide gels in Tris-borate-EDTA. The gels were blotted
onto positively charged nylon membranes (Roche) and developed
by an anti-DIG antibody coupled to alkaline phosphatase (Roche).
CDP-Star (Roche) was used as substrate for the alkaline
phosphatase. Antibody supershift analyses were performed with
a monoclonal anti-c-Myc antibody (Clontech). The EMSA
binding buffer was used to prepare the working dilution. Nuclear
extracts, antibody, and probe were incubated at RT for 45 min
before this reaction mixture was loaded on 6% acrylamide gels.
Yeast one-hybrid screen
Yeast one-hybrid screen was carried out according to the
manufacturer’s protocol (MATCHMAKER One-Hybrid System;
Clontech). Briefly, three tandem copies of the 20 bp cis-acting
Figure 5. RNF10 negatively regulates Schwann cell prolifera-
tion. (A)The time course of cell number was assessed for Schwann cells
infected with retrovirus expressing RNF10 siRNA, or control EGFP siRNA
by using the MTT assay. Compared to control cells, the RNF10-
knockdown Schwann cells exhibited a 40% greater increase. (B) BrdU
incorporation was significantly increased (80% greater) in stable RNF10
knockdown cells compared with controls. *p,0.01; Student’s t test.
Error bars show mean6SD.
doi:10.1371/journal.pone.0003464.g005
Figure 6. Knockdown of RNF10 in Schwann cells inhibits
myelin formation. (A) In vitro myelination using either control EGFP
siRNA or RNF10 siRNA retrovirus-infected Schwann cells. Many MBP-
positive myelin profiles were detected in cocultures containing the
EGFP siRNA-expressing Schwann cells but not in the cocultures
containing the RNF10 siRNA-expressing Schwann cells. Similar neurite
outgrowth was observed between both cultures. No difference was
observed in the cell density between both the cultures. Insets are
higher magnification of boxes, respectively. Bar,100 m. (B) Quantifica-
tion of myelin profiles in control and RNF10 siRNA panels. Percent
myelination value was calculated from 3 independent in vitro
myelination experiments.
doi:10.1371/journal.pone.0003464.g006
RNF10 Regulates Myelination
PLoS ONE | www.plosone.org 9 October 2008 | Volume 3 | Issue 10 | e3464Element (SSE; 59- ACAAGGGCCCCTTTGTGCCC -39) were
synthesized, annealed, and cloned into the pHIS2 bait vector. The
SMART cDNA Library Construction Kit (Clontech) was used to
synthesize cDNA from primary cultured rat Schwann cells. The
isolated cDNA and Sma-I linearized pGADT7-Rec2 vector and
bait vector were then transformed into yeast strain Y187, and the
transformants were selected on SD/-His/-Leu/-Trp medium
containing 15 mM 3AT (Sigma). The plasmids from positive
yeast colonies were isolated and transformed into DH5a bacterial
competent cells and each cDNA insert was sequenced, and
BLAST searched.
Chromatin immunoprecipitation(ChIP) assays
For overexpression experiments, Schwann cells were infected
with retrovirus to express Myc epitope-tagged RNF10 and selected
by puromycin. ChIP assays were performed using a commercial
kit (Upstate Biotechnology) as described by the manufacturer.
Briefly, DNA was crosslinked to protein with formaldehyde.
Cellular lysates were obtained by scraping, followed by pulsed
ultrasonication to shear cellular DNA. For immunoprecipitation,
anti-Myc antibody (Upstate Biotechnology) or mouse IgG
(negative control) was added overnight at 4uC. On the next day,
the crosslinks were reversed, and bound DNA was purified. PCR
to detect the SSE region (2162/2143) was performed with the
following primers: 59- TCTCCAGGAAGGAGTTAGTAGGAG-
39,5 9- ACCACTAAGGTCTTTGGTTGGTTT-39 (2217/
+212). Primers amplifying the promoter region of the rat Gapdh
gene were used as a negative control (forward, 59-AAACAAGTT-
CACCACCATGTGAAA-39; reverse, 59-CCAGGGATTGAC-
CAAAGGTGAGTT-39).
RNAi
siRNA-expressing plasmid vector driven by mouse U6 promoter
(piGENE mU6 vector: iGENE) were constructed according to the
the manufacturer’s protocol. 62-base DNA oligonucleotides
corresponding to sense target sequence, hairpin loop, and
antisense target sequence were synthesized (invitrogen), annealed
together, and then ligated into piGENE mU6 vector. The
oligonucleotides synthesized for RNAi were as follows: 59-
GTTTGGAGAGAATTCAGATGGATTCGTGTGCTGTCCG-
GATCCATTTGAGTTCTTTCCTTTTT -39 and 59- ATG-
CAAAAAGGAAAGAACTCAAATGGATCCGGACAGCACA-
CGAATCCATCTGAATTCTCTCC -39 (RNF10) and; 59-
GTTTGGCTATGTCCGGGAGTGCATCGTGTGCTGTCC-
GGTGCGCTCCTGGACGTAGCCTTTTT -39 and 59-ATG-
CAAAAAGGCTACGTCCAGGAGCGCACCGGACAGCAC-
ACGATGCACTCCCGGACATAGCC -39 (enhanced green
fluorescent protein; EGFP).
For stable gene knockdown the pMX–puro (kindly provided by
T. Kitamura, University of Tokyo, Japan) vector was used [23].
The mouse U6 gene promoter and shRNA sequence from
piGENE mU6 was subcloned into pMX–puro vector, yielding
pMX–puro mU6/siRNA. The generated retroviral construct was
used to produce recombinant viruses and infect the indicated cells.
Infected schwann cells were selected with 1 mg/ml puromycin for
48 h.
Real-time reverse transcription-PCR
Total RNA was isolated using Isogen (Wako). Total RNA (1 mg)
was used in a reverse transcription (RT) reaction with the
QuantiTect Reverse Transcription kit (Qiagen), according to the
manufacturer’s instructions. cDNA was used as template in real-
time PCR assays based on SYBR Green detection with the ABI
Prism 7000 Sequence Detection system. PCR primers were as
follows:
MAG forward, 59-GACAAGAAGAAAAAAGAACGTCACAGA;
MAG reverse, 59-AGGCGCTTCTCACTCTCATACTTATCA;
RNF10forward,59-TATTCCATGTCTGAGGATGTTCGACA;
RNF10 reverse, 59-TCTCAATGTCATCTGAGAACATCTCT;
GAPDH forward, 59-TCCTGCACCACCAACTGCTTAG;
GAPDH reverse, 59-GATGACCTTGCCCACAGCCTTG.
Cell proliferation assay
Cell proliferation was evaluated in 96-well plates by the
modified MTT method designated WST-8 as indicated in the
manufacture’s instruction (Dojindo Laboratories). Briefly,
Schwann cells were seeded into 96-well tissue culture plates at a
concentration of 3610
3 cells/well and incubated in DMEM with
10% FBS and antibiotics at 37uC. After 3 h (day0), 48 h (day2),
72 h (day4), 96 h (day6), the absorbance at the 490-nm
wavelength was measured using an automated microplate reader
(Bio-Tek Instruments).
BrdU incorporation assays were performed by incubating cells
in 24-well culture plates and labeling with 10 mM bromodeoxy-
uridine (BrdU) in medium for 18 h. Afterward, the cells were fixed
for 20 min in 4% paraformaldehyde. For BrdU immunocyto-
chemistry, the cells were then treated with MeOH for 10 min at
4 d, followed by 2 M HCl for 30 minutes at room temperature,
and reacted with primary and secondary antibodies using standard
protocols. The cells were counterstained with the nuclear stain
DAPI. The percentage of cells that had incorporated BrdU was
quantified by determining the ratio of BrdU-positive nuclei and
the total number of nuclei in 15 systematically sampled
microscopic fields.
Western blotting
Rat Schwann cells on 60 mm plates were lysed in M-Per
TM
mammalian protein extraction reagent (Pierce) containing a
complete
TM mini protease inhibitor cocktail tablet (Roche).
Samples containing an equal amount of protein (10 mg) were
analyzed by SDS-PAGE. Proteins were then transferred to a
PVDF membrane (Bio-Rad). Primary antibodies (anti-MAG;
MAB1567, Chemicon) were used in 1:1000 dilution at room
temperature for 1 hr in 3%BSA TBS plus Tween 20. The
secondary antibodies were used in 1:10,000 dilution, and the
immunoblots were developed by using the ECL system (Amer-
sham Biosciences).
Myelination assay
DRG neuron coculture with Schwann cells was performed
using the modified method of Einheber et al. [24]. Briefly, DRGs
were taken from E15 rats, dissociated with trypsin, and seeded on
12 mm dishes coated with collagen type I at 200,000 cells per well.
Non-neuronal cells were removed by treating cultures with C
media (MEM, 10% FBS, 0.4% glucose, and 100 ng/ml 2.5S
NGF) supplemented with uridine, and AraC (at 10 mM) or with C
media alone every 2–3 d alternately for 10 d. For myelination,
250,000 retroviral-infected Schwann cells were seeded onto DRG
cultures in DMEM/F12 medium with N2 supplement (Gibco) and
50 ng/ml NGF and kept for several days until axons were
populated by Schwann cells. The medium was then switched to C
media with 50 ng/ml ascorbic acid to promote myelination.
Cocultures were kept for 2 weeks and then fixed with 4%
paraformaldehyde, and anti-MBP and anti-Tuj1 antibody diluted
at 1:200 in TBST with 3% BSA was applied overnight at room
temperature. Secondary antibodies were then added to observe
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number of myelin-forming Schwann cells were counted by
surveying 20 fields at 200_magnification from three independent
experiments and expressed by percentage ratio to that in control
cultures. The average was calculated, and p- values were obtained
using Student’s t- test.
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